Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-23-046801
Filing Date
2023-09-06
Accepted
2023-09-06 17:52:23
Documents
1
Period of Report
2023-09-01

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5365
  Complete submission text file 0000950170-23-046801.txt   6742
Mailing Address ONCOSEC MEDICAL INCORPORATED 24 NORTH MAIN STREET PENNINGTON NJ 08534
Business Address
DALESANDRO MARGARET (Reporting) CIK: 0001208853 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40505 | Film No.: 231240385

Mailing Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037 (858) 875-2400
Ambrx Biopharma Inc. (Issuer) CIK: 0001836056 (see all company filings)

EIN.: 571147346 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)